- News Home
6 March 2014 1:04 pm ,
Vol. 343 ,
Considered an icon of conservation science, researchers at World Wildlife Fund (WWF) headquarters in Washington, D.C.,...
The new atlas, which shows the distribution of important trace metals and other substances, is the first product of...
Early in April, the first of a fleet of environmental monitoring satellites will lift off from Europe's spaceport in...
Since 2000, U.S. government health research agencies have spent almost $1 billion on an effort to churn out thousands...
Magdalena Koziol, a former postdoc at Yale University, was the victim of scientific sabotage. Now, she is suing the...
Antiretroviral drugs can protect people from becoming infected by HIV. But so-called pre-exposure prophylaxis, or PrEP...
Two studies show that eating a diet low in protein and high in carbohydrates is linked to a longer, healthier life, and...
- 6 March 2014 1:04 pm , Vol. 343 , #6175
- About Us
Scratch That Gene
25 July 2007 (All day)
Scratchers of the world take heart. Researchers have identified the first gene in the central nervous system that is responsible for itching. Although other itch genes are known, this is the first one directly linked to the brain and could pave the way for novel drugs to sooth serious itching.
The irritating culprit made by the gene is gastrin-releasing peptide receptor (GRPR). Researchers have been studying the gene for its role in pain, but no one ever tied it to itching. A team led by geneticist Zhou-Feng Chen of Washington University School of Medicine in St. Louis, Missouri, started looking at GRPR because it was interested in pain genes. GRPR is found only in a few spinal nerve cells that send pain and itch signals to the brain. The team soon discovered that the receptor wasn't essential to perceiving pain; mice whose GRPR genes had been knocked out responded normally to various types of pain from heat, inflammation, and mechanical pressure.
The researchers then tested whether GRPR is required for feeling itchy by injecting several itch-inducing compounds into the knockout mice, including histamines--the substances responsible for the itchiness of allergies. The mutant mice didn't scratch anywhere near as much as the normal mice did in response to the injections. Conversely, when the scientists injected normal mice with a substance mimicking the gastrin-releasing peptide, they scratched even more, the team reports online today in Nature.
The authors believe this signaling pathway offers a promising new target for chronic itching. This problem, often intractable, stems from a host of maladies, from skin disorders to tumors.
"It's an excellent study and provides a new molecular target ... that may be exploited to relieve itch," says Earl Carstens, a neuroscientist at the University of California, Davis.
Jeffrey Mogil, who heads the pain genetics lab at McGill University in Montreal, Canada, seconds that conclusion, calling GRPR "an eminently druggable target."